Skip to content

Bibliography

Below is a pull of my current publications from OpenAlex in no particular order.

  1. Foster-Nyarko E, Cottingham H, Wick RR, Judd LM, Lam MMC, Wyres KL, et al. Nanopore-only assemblies for genomic surveillance of the global priority drug-resistant pathogen, Klebsiella pneumoniae. Microbial Genomics. 2023;9(2). DOI

  2. Stanton TD, Hetland MAK, Löhr IH, Holt KE, Wyres KL. Fast and accurate in silico antigen typing with Kaptive 3. Microbial Genomics. 2025;11(6). DOI

  3. Stanton TD, Wyres KL. What defines hypervirulent Klebsiella pneumoniae?. EBioMedicine. 2024;108:105331. DOI

  4. Cottingham H, Judd LM, Wisniewski JA, Wick RR, Stanton TD, Vezina B, et al. Targeted sequencing of Enterobacterales bacteria using CRISPR-Cas9 enrichment and Oxford Nanopore Technologies. mSystems. 2025;10(2):e0141324. DOI

  5. Nonne F, Molfetta M, Belciug GF, Carducci M, Cianchi V, Zakroff C, et al. The characterization of Klebsiella pneumoniae associated with neonatal sepsis in low- and middle-income countries to inform vaccine design. Communications Biology. 2025;8(1):898. DOI

  6. Oo G, Low WW, Yong M, Stanton TD, Ayuni NN, Bifani P, et al. Anti-plasmid defense in hypervirulent Klebsiella pneumoniae involves Type I-like and Type IV restriction modification systems. Emerging Microbes & Infections. 2025;14(1):2558877. DOI

  7. Oo G, Low WW, Yong M, Stanton TD, Ayuni NN, Bifani P, et al. Anti-plasmid defense in hypervirulent Klebsiella pneumoniae involves Type I-like and Type IV restriction modification systems. National University of Singapore. 2025;.

Comments